Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 | 161841765 | intron variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2011 | 2011 | |||||||||||
|
1.000 | 0.080 | 1 | 161787246 | intron variant | A/T | snv | 0.21 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1 | 161892765 | intron variant | G/A | snv | 0.49 |
|
0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
1.000 | 0.080 | 1 | 161805787 | intron variant | A/G | snv | 0.21 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 1 | 161823822 | intron variant | G/A | snv | 0.20 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1 | 161897699 | intron variant | G/A | snv | 0.49 |
|
0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
0.882 | 0.120 | 1 | 161816705 | intron variant | A/G | snv | 2.1E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.120 | 1 | 161816705 | intron variant | A/G | snv | 2.1E-02 |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.882 | 0.120 | 1 | 161816705 | intron variant | A/G | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1 | 161879595 | intron variant | A/C | snv | 0.49 |
|
0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
1.000 | 0.080 | 1 | 161913293 | intron variant | G/A | snv | 0.21 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1 | 161769400 | intron variant | A/G | snv | 0.49 |
|
0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
1 | 161771484 | intron variant | T/C | snv | 0.49 |
|
0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
1 | 161853828 | intron variant | A/G | snv | 0.49 |
|
0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
0.827 | 0.280 | 1 | 161791486 | missense variant | G/C | snv | 0.14 | 9.2E-02 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
|
0.925 | 0.120 | 1 | 161819693 | missense variant | C/T | snv | 1.6E-05 | 5.6E-05 |
|
0.800 | 1.000 | 2 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 1 | 161781951 | missense variant | A/G;T | snv | 0.23; 8.0E-06 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.080 | 1 | 161791522 | missense variant | C/T | snv | 0.15 | 0.12 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
|
0.827 | 0.280 | 1 | 161791486 | missense variant | G/C | snv | 0.14 | 9.2E-02 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.827 | 0.280 | 1 | 161791486 | missense variant | G/C | snv | 0.14 | 9.2E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.827 | 0.280 | 1 | 161791486 | missense variant | G/C | snv | 0.14 | 9.2E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
|
0.827 | 0.280 | 1 | 161791486 | missense variant | G/C | snv | 0.14 | 9.2E-02 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.827 | 0.280 | 1 | 161791486 | missense variant | G/C | snv | 0.14 | 9.2E-02 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||
|
0.925 | 0.120 | 1 | 161819693 | missense variant | C/T | snv | 1.6E-05 | 5.6E-05 |
|
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.925 | 0.120 | 1 | 161863292 | missense variant | T/A | snv |
|
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 |